Category: Federal Forum Posters
Purpose: In January 2018, the William Jennings Bryan Dorn VA Medical Center implemented a rapid blood culture identification panel (BCID) that identifies the pathogens in positive blood cultures in slightly over an hour. The rapid reporting of organisms allows for appropriate de-escalation of therapy more rapidly than traditional methods. The purpose of this study is to retrospectively evaluate the impact of a BCID panel on the duration of broad spectrum antibiotic therapy in veterans with gram stain positive blood cultures.
Methods: This retrospective, pre-post intervention matched cohort study was conducted at the William Jennings Bryan Dorn Veterans Affairs Medical Center during the time frame of 2016-2018. The patient population will include veterans admitted for at least 48 hours with gram stain positive blood cultures who were on empiric antibiotic therapy during the study period. Patients meeting inclusion criteria from the post-intervention (after BCID implementation) group will be matched by organism to the pre-intervention group (prior to BCID implementation). The primary outcome is the duration of vancomycin therapy for gram positive bacteremia and the duration of anti-pseudomonal beta lactam therapy for gram negative bacteremia. The secondary outcomes include time from blood culture collection to organism identification, hospital length of stay, 30-day all-cause mortality, and 30-day all-cause readmission.
Results: Not applicable
Conclusion: Not applicable
Alexandra Herman– PGY1 Pharmacy Resident, William Jennings Bryan Dorn VA Medical Center, Columbia, SC